Breathwork reduces stress and anxiety
- Trial ID
- NCT06581523
- Official Title
- A Feasibility and Efficacy Study of a Breathwork and Meditation Intervention (SKY Breath) on the Psychophysiological Well-Being of Individuals With Parkinson's Disease (iPD) and Their Care Partners
- Goal
- Breathwork reduces stress and anxiety
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Nova Southeastern University
- Study Type
- INTERVENTIONAL
- Enrollment
- 40 participants
- Conditions
- Parkinson's Disease
- Interventions
- SKY Breath and Meditation
Plain-Language Summary
The goal is to reduce stress, anxiety, and improve overall psychophysiological well-being for people with early to mid-stage Parkinson's and their unpaid care partners. The approach teaches SKY Breath, a structured breathwork and meditation program that uses guided rhythmic breathing and relaxation to shift the autonomic nervous system toward more parasympathetic activity, improve heart rate variability, and lower stress and mood symptoms. It is a non-drug intervention, so it does not pharmacologically interact with levodopa, though the study will look at whether the practice helps coping and daily function alongside usual medications. The study is looking for adults 18 to 75 with Parkinson's stage 1 to 3 who can follow and remember the breathing steps, read and speak English, attend online sessions and an in-person training, and also seeks their unpaid care partners; people with advanced PD, certain psychiatric or seizure disorders, uncontrolled hypertension, or active substance use are excluded.
Locations
- Raw Kickboxing and Fitness, Coral Springs, Florida, United States
- David Posnack Jewish Community Center, Davie, Florida, United States
- Nova Southeastern University, Fort Lauderdale, Florida, United States
Frequently Asked Questions
- What is this trial testing?
- This trial is studying SKY Breath and Meditation. The goal is to reduce stress, anxiety, and improve overall psychophysiological well-being for people with early to mid-stage Parkinson's and their unpaid care partners. The approach teaches SKY Breath, a structured breathwork and meditation program that uses guided rhythmic breathing and relaxation to shift the autonomic nervous system toward more parasympathetic activity, improve heart rate variability, and lower stress and mood symptoms. It is a non-drug intervention, so it does not pharmacologically interact with levodopa, though the study will look at whether the practice helps coping and daily function alongside usual medications. The study is looking for adults 18 to 75 with Parkinson's stage 1 to 3 who can follow and remember the breathing steps, read and speak English, attend online sessions and an in-person training, and also seeks their unpaid care partners; people with advanced PD, certain psychiatric or seizure disorders, uncontrolled hypertension, or active substance use are excluded.
- Who can participate?
- Participants must be between 18 Years and 75 Years.
- Where is this trial located?
- This trial is recruiting at 3 locations.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 6 months.